Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer

NCT ID: NCT04230772

Last Updated: 2020-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

550 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators will compare the clinical outcomes of the natural orifice specimen extraction surgery versus traditional robotic-assisted surgery in the treatment of colorectal cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on investigators' experience, compared to robotic-assisted colorectal cancer radical resection, robotic colorectal cancer radical resection with natural orifice extraction has more advantages in postoperative stress response, postoperative pain, postoperative recovery and postoperative abdominal aesthetics. However, in terms of tumor radicality, there may be no obvious differences. There are no randomized controlled trails to discuss these questions.This research is based on the above conditions. Investigators use prospective randomized controlled trial to analyze the surgical data, postoperative complications, postoperative recovery of the robotic colorectal cancer radical resection with natural orifice extraction and conventional robotic-assisted colorectal cancer radical resection in order to summarize clinical experience and explore the advantages and disadvantages of robotic colorectal cancer radical resection with natural orifice specimen extraction and to provide a new direction for the surgical treatment of colorectal cancer, which is beneficial to the promotion of NOSES(Natural Orifice Specimen Extraction Surgery ) technology and treatment of colorectal cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Neoplasms Neoplasms Malignant Complication of Surgical Procedure Robotic Surgical Procedures Natural Orifice Specimen Extraction Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Natural Orifice Specimen Extraction Surgery

Natural orifice specimen extraction surgery will performed in patients assigned to this group.

Group Type EXPERIMENTAL

Natural Orifice Specimen Extraction Surgery

Intervention Type PROCEDURE

In the experimental group, patients will be performed robotic colorectal resection with natural orifice specimen extraction.

Traditional Robotic-assisted Surgery

Traditional robotic-assisted surgery will performed in patients assigned to this group.

Group Type ACTIVE_COMPARATOR

Traditional Robotic-assisted Surgery

Intervention Type PROCEDURE

In the active comparator group, patients will be performed traditional robotic-assisted colorectal resection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Natural Orifice Specimen Extraction Surgery

In the experimental group, patients will be performed robotic colorectal resection with natural orifice specimen extraction.

Intervention Type PROCEDURE

Traditional Robotic-assisted Surgery

In the active comparator group, patients will be performed traditional robotic-assisted colorectal resection.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥ 18 and ≤ 80 years;
2. Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale;
3. Histological or cytological confirmation of colorectal adenocarcinoma;
4. High rectal and sigmoid cancer with the lower margin of the tumor greater than 10 cm from the anal dentate line;
5. T1-3N0M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition, Transvaginal NOSES procedure w specimen with a circumferential diameter of \<5 cm;
6. Preoperative examination did not suggest distant metastasis, implantation or invasion of adjacent organs;
7. Cardiopulmonary liver and kidney function can withstand surgery;
8. Written informed consent for participation in the trial.

Exclusion Criteria

1. Not suitable for robot laparoscopic surgery;
2. The tumor is too large to be pulled out through the anus or vagina;
3. Simultaneous multiple primary cancer;
4. Emergency surgery due to complication (bleeding, obstruction or perforation) caused by primary cancer
5. Women with acute gynecological infections, vaginal deformities, unmarried and infertile women and women who are married and plan to get pregnant.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taiyuan Li

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Taiyuan Li

Prof., Chief physician, Head of The Fifth Department of General Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Taiyuan Li, M.D., Ph.D

Role: PRINCIPAL_INVESTIGATOR

Department of General Surgery, The First Affiliated Hospital of Nanchang University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chinese PLA General Hospital (301 Hospital) China

Beijing, Beijing Municipality, China

Site Status RECRUITING

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

Site Status RECRUITING

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

Site Status RECRUITING

First Affiliated Hospital of Gannan Medical College

Ganzhou, Jiangxi, China

Site Status RECRUITING

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status RECRUITING

The Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status RECRUITING

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Taiyuan Li, M.D., Ph.D

Role: CONTACT

+86-13970031518

Dongning Liu, M.D., Ph.D

Role: CONTACT

+86-13576982921

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Baoqing Jia, M.M., Ph.D

Role: primary

Yanan Wang, M.M., Ph.D

Role: primary

Hongliang Yao, M.M., Ph.D

Role: primary

Xiangfu Zeng, M.M., Ph.d

Role: primary

Taiyuan Li, M.M., Ph.D

Role: primary

13970031518

Shengxun Mao, MM., Ph.D

Role: primary

Ye Wei, M.M.,Ph.D

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Luo R, Zheng F, Zhang H, Zhu W, He P, Liu D. Robotic natural orifice specimen extraction surgery versus traditional robotic-assisted surgery (NOTR) for patients with colorectal cancer: a study protocol for a randomized controlled trial. Trials. 2021 Feb 6;22(1):121. doi: 10.1186/s13063-021-05077-z.

Reference Type DERIVED
PMID: 33549133 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ndyfy660618

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.